Acute exposure to traffic-related air pollution can lead to lower airway neutrophils to release of neutrophil extracellular traps, which is linked to COPD severity and airflow limitations.
Researchers have proposed that the COPD Assessment Test (CAT) be used as a US Food and Drug Administration (FDA) clinical outcomes assessment tool.
There is significant disparity in the ratios for postbronchodilator FEV1/FEV6 and FEV1/FVC %, and this disparity is very pronounced in women.
Sputum cell count, as measured by a simplified method, was able to differentiate between asthma, COPD, and asthma-COPD overlap.
In many countries, chronic obstructive pulmonary disease rates are decreasing, although the absolute number of deaths is increasing.
Researchers sought to identify the association between disinfectants and cleaning products with the incidence of COPD in nurses.
Depression is linked to increased clinical burden in patients with COPD.
Researchers conducted a retrospective analysis to identify seasonal variations in outcomes for COPD exacerbation admissions and the effect on healthcare resource utilization.
Challenges pertaining to the correct use of inhalers for asthma and COPD can limit the effectiveness of treatment.
Home-based pulmonary rehabilitation improves long-term exercise tolerance and quality of life in patients with severe asthma.
Results from an umbrella review of observational studies showed highly suggestive or suggestive evidence for HIV and the presence of several physical health outcomes.
Patients with asthma and/or chronic obstructive pulmonary disease have an increased risk for the development of long-term lower back pain.
Larger effects seen for people from lower-income households.
As primary care clinicians are on the front lines of care for patients with COPD, they should educate them on the disease process, medication regimens, and nonpharmacologic treatments.
Prevalence of COPD higher in southeastern and Appalachian states, regardless of smoking status.
Substantial contribution seen to burden of diseases including asthma, COPD, chronic bronchitis, fibrosis.
Women are more likely to be symptomatic, have greater odds of frequent, severe acute exacerbations.
Individuals with HDHP more likely to report forgoing care due to costs, cost-related nonadherence.
Ginseng is nonsuperior to placebo for improving health-related quality of life in patients with stable symptomatic COPD.
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.